Sudthida Vasavanonda
Abbott Fund(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Click Chemistry and Applications, Biochemical and Molecular Research, Hepatitis C virus research
Most-Cited Works
- → Ordered accumulation of mutations in HIV protease confers resistance to ritonavir(1996)766 cited
- → ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.(1995)553 cited
- → ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease(1998)468 cited
- → Structure-based, C2 symmetric inhibitors of HIV protease(1990)211 cited
- → Discovery of Ritonavir, a Potent Inhibitor of HIV Protease with High Oral Bioavailability and Clinical Efficacy(1998)204 cited
- → Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus(1998)177 cited
- → Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease(1991)135 cited
- → Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diol(1993)130 cited
- → Design of orally bioavailable, symmetry-based inhibitors of HIV protease(1994)56 cited
- → Novel lopinavir analogues incorporating non-Aromatic P-1 side chains—Synthesis and structure–Activity relationships(2002)52 cited